When asked what Moleculent’s cell-cell interaction mapping technology provides to translational researchers, CEO Olle Ericsson explained that it adds “a new layer of information,” specifically ...
LYON, France--(BUSINESS WIRE)--Regulatory News: MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem Therapies ...
As was revealed a week ago in a Tesla app decompiling, the EV maker re-launched its Early Access Program. The program is specifically focused on testing Full Self-Driving builds, and so far, invites ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback